Healome Therapeutics

Developing Solutions for Ocular Surface Diseases

Founded 2021 · $2.5M raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$2.5M
Last Round
$2.5M SeedJul 2026
Rounds
1

About

Healome Therapeutics is an ophthalmology and ocular drug delivery company aiming to improve the safety, effectiveness, and usability of ocular drugs and treatment of ocular surface conditions. Healome has developed an eye drop matrix technology that behaves like a liquid when dropped on the eye, then restructures into a clear, lubricating, protective matrix able to deliver a broad range of drugs, from small molecules to complex biologics. The company aims to enhance the therapeutic value of existing ocular medicines through reformulation and to develop novel therapeutics that could transform the management of ocular surface health.

Summary

Healome Therapeutics is a Biotech company, founded in 2021. It has raised $2.5M in total across 1 round, most recently a $2.5M Seed round in Jul 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJul 2026
$2.5M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Healome Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/healome-therapeutics"><img src="https://indexed.vc/api/badge/company/healome-therapeutics" alt="Healome Therapeutics on Indexed.vc" width="260" height="76" /></a>